Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Citeline Podcasts

Scrip M&A Podcast: Will the FDA Staff Cuts Affect Biopharma M&A Activity?

01 May 2025

Description

Scrip senior writer Joseph Haas discusses the potential impact of the recent FDA staff cuts with attorneys Andrew Goodman of Paul Hastings LLP and Alan Minsk of Arnall Golden Gregory, as well as Naya Therapeutics CEO Daniel Teper

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.